Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Work In Process (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Work In Process data on record, last reported at $29.2 million in Q4 2025.

  • For Q4 2025, Work In Process rose 11.0% year-over-year to $29.2 million; the TTM value through Dec 2025 reached $29.2 million, up 11.0%, while the annual FY2025 figure was $28.0 million, 18.82% up from the prior year.
  • Work In Process reached $29.2 million in Q4 2025 per PAHC's latest filing, up from $25.8 million in the prior quarter.
  • Across five years, Work In Process topped out at $29.2 million in Q4 2025 and bottomed at $10.1 million in Q3 2021.
  • Average Work In Process over 5 years is $20.8 million, with a median of $23.0 million recorded in 2023.
  • Peak YoY movement for Work In Process: decreased 2.74% in 2021, then soared 72.97% in 2022.
  • A 5-year view of Work In Process shows it stood at $11.9 million in 2021, then skyrocketed by 68.34% to $20.0 million in 2022, then grew by 25.27% to $25.1 million in 2023, then grew by 5.05% to $26.3 million in 2024, then grew by 11.0% to $29.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $29.2 million in Q4 2025, $25.8 million in Q3 2025, and $28.0 million in Q2 2025.